Evidence map›Paper›PMID 30060570›Full record

ReviewInternational journal of molecular sciences2018

Chemopreventive Effects of Phytochemicals and Medicines on M1/M2 Polarized Macrophage Role in Inflammation-Related Diseases.

Yen-Chun Koh, Guliang Yang, Ching-Shu Lai, Monthana Weerawatanakorn, Min-Hsiung Pan

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Therapeutic and Pharmaceutical Potential ofAntioxidants (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. ACS omega · 2024
    Article
  14. Article
  15. Article
  16. Type I Cystatin Derived fromMicroorganisms · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Yen-Chun KohInstitute of Food Science and Technology, National Taiwan University, Taipei 10617, Taiwan. yenkoh0123@gmail.com.ORCID 0000-0001-7683-873X
Guliang YangHubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization, Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains, Huanggang Normal University, Huanggang 410083, China. guliangyang@163.com.
Ching-Shu LaiDepartment of Seafood Science, National Kaohsiung Marine University, Kaohsiung 811, Taiwan. chlai@mail.nkmu.edu.tw.
Monthana WeerawatanakornFaculty of Agriculture Natural Resources and Environment, Naresuan University, Phitsanulok 65000, Thailand. monthanac@nu.ac.th.
Min-Hsiung PanInstitute of Food Science and Technology, National Taiwan University, Taipei 10617, Taiwan. mhpan@ntu.edu.tw.ORCID 0000-0002-5188-7030
Huanggang Normal University · CNNaresuan University · THNational Kaohsiung Marine University · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages can polarize into two different states (M1 and M2), which play contrasting roles during pathogenesis or tissue damage. M1 polarized macrophages produce pro-inflammatory cytokines and mediators resulting in inflammation, while M2 macrophages have an anti-inflammatory effect. Secretion of appropriate cytokines and chemokines from macrophages can lead to the modification of the microenvironment for bridging innate and adaptive immune responses. Increasing evidence suggests that polarized macrophages are pivotal for disease progression, and the regulation of macrophage polarization may provide a new approach in therapeutic treatment of inflammation-related diseases, including cancer, obesity and metabolic diseases, fibrosis in organs, brain damage and neuron injuries, and colorectal disease. Polarized macrophages affect the microenvironment by secreting cytokines and chemokines while cytokines or mediators that are produced by resident cells or tissues may also influence macrophages behavior. The interplay of macrophages and other cells can affect disease progression, and therefore, understanding the activation of macrophages and the interaction between polarized macrophages and disease progression is imperative prior to taking therapeutic or preventive actions. Manipulation of macrophages can be an entry point for disease improvement, but the mechanism and potential must be understood. In this review, some advanced studies regarding the role of macrophages in different diseases, potential mechanisms involved, and intervention of drugs or phytochemicals, which are effective on macrophage polarization, will be discussed.

Indexed as

AnimalsCell PolarityCytokinesHumansInflammationMacrophage ActivationMacrophagesPhytochemicalsCytokinesPhytochemicalschemopreventioninflammationM1/M2 macrophagephytochemicals

Identifiers

PMID30060570
PMCPMC6121620
OpenAlexW2883519846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.